Categories Cancer

Seeking to expand targeted therapy for lung cancer

Seeking to expand targeted therapy for lung cancer Hunting down RIT1-driven lung cancer’s unique vulnerabilities Berger was inspired to seek out new therapeutic targets for lung cancer by the clinical advances seen for therapies that target other lung cancer-associated mutations. She linked several new genes to lung cancer — including mutated RIT1 — while participating in The Cancer Genome […]

Read More
Categories Uncategorized

Cluster Headache Market to Expand at 5.30% CAGR, Growing Demand Calls for Better Treatment …

Cluster Headache Market to Expand at 5.30% CAGR, Growing Demand Calls for Better Treatment … – The Cluster Headache market garners colossal growth backed by increased prevalence and the expected launch of novel therapies during the forecast period (2018–2030) LAS VEGAS, April 7, 2021 /PRNewswire/ — DelveInsight’s “Cluster Headache Market” report provides a thorough comprehension […]

Read More
Categories Multiple Myeloma

LAUGH FOR A GOOD CAUSE: Bargatze to headline charity comedy event

LAUGH FOR A GOOD CAUSE: Bargatze to headline charity comedy event Laughs 4 Life returns for yet another night of comedic relief and fundraising Friday, July 30 at Hattiesburg’s historic Saenger Theater. Headlining this year’s event will be Nate Bargatze, one of comedy’s fasting-rising stars. Joining Bargatze will be special guest opener and fellow Tennessean […]

Read More
Categories Parkinson's Disease

E1/T1 Transceivers (LIU/Framer) Market 2016,Global Industry Analysis, Size, Share And Growth Forecas

Intense Research releases a new market research report “E1/T1 Transceivers (LIU/Framer) Market Opportunities, Strategies, and Forecasts, Worldwide, 2011 to 2017” to add to its collection of research reports. E1/T1 Transceivers (LIU/Framer) Market Shares and Forecasts, Worldwide, 2011-2017. The 2011 study has 221 pages, 76 tables and figures. E1/T1 transceiver (LIU/Framer)technology gives service providers more network […]

Read More
Categories Multiple Myeloma

The Multiple Myeloma Research Foundation

The Multiple Myeloma Research Foundation The Multiple Myeloma Research Foundation (MMRF) helps accelerate the development of next generation multiple myeloma treatments to extend patient’s lives, and lead to a cure. MMRF brings treatment to multiple myeloma patients 60% faster than the average through collaboration with best in class partners in the US and Internationally. In […]

Read More
Categories Cancer

Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research

Volastra Therapeutics Partners with Microsoft to Advance Metastatic Cancer Research NEW YORK–(BUSINESS WIRE)–Volastra Therapeutics today announced it will collaborate with Microsoft to develop tools that help detect drivers of cancer metastasis. These unique digital pathology tools will accelerate the development of promising new therapies for cancer and help identify the patients most likely to benefit. […]

Read More
Categories Cancer

Overview of The Current Progress of Facultative Anaerobic Bacteria in Cancer Biotherapy with TNF …

Overview of The Current Progress of Facultative Anaerobic Bacteria in Cancer Biotherapy with TNF … [unable to retrieve full-text content] This review article focuses on the use of infectious bacteria as delivery tool for tumour necrosis factor alpha, a well-studied cytokine, in the context of …Published at Tue, 06 Apr 2021 11:15:14 +0000

Read More
Categories Multiple Myeloma

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory …

MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory … – MitoImmune initiates a Phase 2 trial of oral mucositis (OM) prevention in the first half of 2021 in the US and Korea, and is expanding OM treatment into hematopoietic stem cell transplantation clinical trials SEOUL, South Korea, April 6, 2021 /PRNewswire/ […]

Read More
Categories Multiple Myeloma

Whole-Genome Sequencing Shows Ability to Identify Progressive Myeloma Precursor

Whole-Genome Sequencing Shows Ability to Identify Progressive Myeloma Precursor In a cohort of patients with monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma, whole-genome sequencing (WGS) identified disease-defining genomic events that successfully identified 2 distinct precursors of multiple myeloma that may be able to stratify individuals as having either progressive or stable disease entities.1 […]

Read More